CDC recommends Doxy pep to prevent bacterial STIS
Advertisement
The CDC recommends doxycycline postexposure prophylaxis (doxy PEP) as part of a comprehensive sexual health strategy to prevent sexually transmitted infections (STIs). Studies have shown that doxy PEP significantly reduces bacterial STIs, such as chlamydia and syphilis, particularly among men who have sex with men (MSM) and transgender women (TGW).
Doxy PEP should be taken as a 200 mg dose within 72 hours after sexual exposure, with the most benefit observed in those with a history of STIs in the past 12 months. These guidelines are based on a systematic review of randomized controlled trials and expert consultations, demonstrating its feasibility and acceptability.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.